Skip to main content
OpenTrials

Clinical trial condition

Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

97 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Recruiting

A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems

NCT06512454

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of South Carolina Charleston, South Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Vienna General Hospital (AKH Wien) Vienna, Austria
View Trial Details
Recruiting

Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency

NCT07715617

Conditions
Alpha-1-antitrypsin Deficiency, Artificial Intelligence (AI), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Hospices Civils de Lyon Bron, France
  • CHU de Lille Lille, France
  • Hôpital BICHAT CLAUDE-BERNARD Paris, France
  • Bordeaux University Hospital Pessac, France
View Trial Details
Recruiting

A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)

NCT07227207

Conditions
Alpha-1 Antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Clinical Study Center Boston, Massachusetts, United States
  • Clinical Study Center Charleston, South Carolina, United States
  • Clinical Study Center Seattle, Washington, United States
  • Clinical Study Center Fitzroy, Victoria, Australia
View Trial Details
Recruiting

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

NCT05677971

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • University of Arizona Thomas D. Boyer Liver Institute Tucson, Arizona, United States
View all 89 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)

NCT06389877

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • Clinical Study Center Birmingham, Alabama, United States
  • Clinical Study Center Boston, Massachusetts, United States
  • Clinical Study Center Charleston, South Carolina, United States
  • Clinical Study Center Adelaide, Australia
View Trial Details
Recruiting

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

NCT06165341

Conditions
Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic - PPDS Phoenix, Arizona, United States
  • University of Arizona Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • University of California San Diego La Jolla, California, United States
View all 41 locations
View Trial Details
Recruiting

PiMZ Longitudinal Cohort (PiMZ Logic)

NCT06505603

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California- Los Angeles Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions